Literature DB >> 34460209

Gene-circuit therapy on the horizon: synthetic biology tools for engineered therapeutics.

Rafał Krzysztoń1, Yiming Wan1, Julia Petreczky1, Gábor Balázsi1.   

Abstract

Therapeutic genome modification requires precise control over the introduced therapeutic functions. Current approaches of gene and cell therapy fail to deliver such command and rely on semi-quantitative methods with limited influence on timing, contextuality and levels of transgene expression, and hence on therapeutic function. Synthetic biology offers new opportunities for quantitative functionality in designing therapeutic systems and their components. Here, we discuss synthetic biology tools in their therapeutic context, with examples of proof-of-principle and clinical applications of engineered synthetic biomolecules and higher-order functional systems, i.e. gene circuits. We also present the prospects of future development towards advanced gene-circuit therapy.

Entities:  

Mesh:

Year:  2021        PMID: 34460209      PMCID: PMC8590856          DOI: 10.18388/abp.2020_5744

Source DB:  PubMed          Journal:  Acta Biochim Pol        ISSN: 0001-527X            Impact factor:   2.149


  97 in total

1.  A synthetic oscillatory network of transcriptional regulators.

Authors:  M B Elowitz; S Leibler
Journal:  Nature       Date:  2000-01-20       Impact factor: 49.962

Review 2.  Gene silencing as a threat to the success of gene therapy.

Authors:  T H Bestor
Journal:  J Clin Invest       Date:  2000-02       Impact factor: 14.808

Review 3.  Minireview: transcriptional regulation in pancreatic development.

Authors:  Joel F Habener; Daniel M Kemp; Melissa K Thomas
Journal:  Endocrinology       Date:  2004-12-16       Impact factor: 4.736

Review 4.  Silencing and variegation of gammaretrovirus and lentivirus vectors.

Authors:  James Ellis
Journal:  Hum Gene Ther       Date:  2005-11       Impact factor: 5.695

5.  Rationally improving LOV domain-based photoswitches.

Authors:  Devin Strickland; Xiaolan Yao; Grzegorz Gawlak; Michael K Rosen; Kevin H Gardner; Tobin R Sosnick
Journal:  Nat Methods       Date:  2010-06-20       Impact factor: 28.547

6.  Adeno-associated virus finds its disease.

Authors:  David W Russell; Markus Grompe
Journal:  Nat Genet       Date:  2015-10       Impact factor: 38.330

7.  An engineered epigenetic transgene switch in mammalian cells.

Authors:  Beat P Kramer; Alessandro Usseglio Viretta; Marie Daoud-El-Baba; Dominique Aubel; Wilfried Weber; Martin Fussenegger
Journal:  Nat Biotechnol       Date:  2004-06-06       Impact factor: 54.908

8.  Rationally designed logic integration of regulatory signals in mammalian cells.

Authors:  Madeleine Leisner; Leonidas Bleris; Jason Lohmueller; Zhen Xie; Yaakov Benenson
Journal:  Nat Nanotechnol       Date:  2010-07-11       Impact factor: 39.213

9.  Optical Control of Peroxisomal Trafficking.

Authors:  Jessica I Spiltoir; Devin Strickland; Michael Glotzer; Chandra L Tucker
Journal:  ACS Synth Biol       Date:  2015-11-02       Impact factor: 5.110

10.  A multi-landing pad DNA integration platform for mammalian cell engineering.

Authors:  Leonid Gaidukov; Liliana Wroblewska; Brian Teague; Tom Nelson; Xin Zhang; Yan Liu; Kalpana Jagtap; Selamawit Mamo; Wen Allen Tseng; Alexis Lowe; Jishnu Das; Kalpanie Bandara; Swetha Baijuraj; Nevin M Summers; Timothy K Lu; Lin Zhang; Ron Weiss
Journal:  Nucleic Acids Res       Date:  2018-05-04       Impact factor: 16.971

View more
  1 in total

1.  Genetic physical unclonable functions in human cells.

Authors:  Yi Li; Mohammad Mahdi Bidmeshki; Taek Kang; Chance M Nowak; Yiorgos Makris; Leonidas Bleris
Journal:  Sci Adv       Date:  2022-05-04       Impact factor: 14.957

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.